aluates Reports

$ 0.0

Automative

Global Androgen Deprivation Therapy (ADT) Market Research Report 2025

Published Date: August 2025

Report Code: QYRE-Auto-7X14896

Global Androgen Deprivation Therapy ADT Market Insights Forecast to 2029

BUY CHAPTERS

Global Androgen Deprivation Therapy (ADT) Market Research Report 2025

Code: QYRE-Auto-7X14896

Report

August 2025

Pages:84

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

Pfizer Inc

Astellas Pharma

Johnson & Johnson

Novartis International

Merck

Veru Inc.

Sanofi

GlaxoSmithKline PLC

Bayer

Orion

Astrazeneca plc

Johnson & Johnson

Androgen Deprivation Therapy (ADT) Market Size

The global market for Androgen Deprivation Therapy (ADT) was valued at US$ 6527 million in the year 2024 and is projected to reach a revised size of US$ 9140 million by 2031, growing at a CAGR of 5.0% during the forecast period.

Androgen Deprivation Therapy (ADT) Market

Androgen Deprivation Therapy is an antihormone therapy whose main use is in treating prostate cancer.

North American market for Androgen Deprivation Therapy (ADT) is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Asia-Pacific market for Androgen Deprivation Therapy (ADT) is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The global market for Androgen Deprivation Therapy (ADT) in Hospital is estimated to increase from $ million in 2024 to $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The major global companies of Androgen Deprivation Therapy (ADT) include Pfizer, Astellas Pharma, Johnson & Johnson, Novartis International, Merck, Veru, Sanofi, GlaxoSmithKline, Bayer, Orion, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

This report aims to provide a comprehensive presentation of the global market for Androgen Deprivation Therapy (ADT), with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Androgen Deprivation Therapy (ADT).

The Androgen Deprivation Therapy (ADT) market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Androgen Deprivation Therapy (ADT) market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Androgen Deprivation Therapy (ADT) companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Androgen Deprivation Therapy (ADT) Market Report

Report Metric	Details
Report Name	Androgen Deprivation Therapy (ADT) Market
Accounted market size in year	US$ 6527 million
Forecasted market size in 2031	US$ 9140 million
CAGR	5.0%
Base Year	year
Forecasted years	2025 - 2031
Segment by Type	Medicine Surgery Other
Segment by Application	Hospital Clinic Other
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Pfizer, Astellas Pharma, Johnson & Johnson, Novartis International, Merck, Veru, Sanofi, GlaxoSmithKline, Bayer, Orion, AstraZeneca
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Androgen Deprivation Therapy (ADT) company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

How fast is Androgen Deprivation Therapy (ADT) Market growing?

Ans: The Androgen Deprivation Therapy (ADT) Market witnessing a CAGR of 5.0% during the forecast period 2025-2031.

What is the Androgen Deprivation Therapy (ADT) Market size in 2031?

Ans: The Androgen Deprivation Therapy (ADT) Market size in 2031 will be US$ 9140 million.

Who are the main players in the Androgen Deprivation Therapy (ADT) Market report?

Ans: The main players in the Androgen Deprivation Therapy (ADT) Market are Pfizer, Astellas Pharma, Johnson & Johnson, Novartis International, Merck, Veru, Sanofi, GlaxoSmithKline, Bayer, Orion, AstraZeneca

What are the Application segmentation covered in the Androgen Deprivation Therapy (ADT) Market report?

Ans: The Applications covered in the Androgen Deprivation Therapy (ADT) Market report are Hospital, Clinic, Other

What are the Type segmentation covered in the Androgen Deprivation Therapy (ADT) Market report?

Ans: The Types covered in the Androgen Deprivation Therapy (ADT) Market report are Medicine, Surgery, Other

Recommended Reports

Hormonal Therapy

Prostate Cancer

Genitourinary Disorders

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Androgen Deprivation Therapy (ADT) Market Size Growth Rate by Type: 2020 VS 2024 VS 2031

1.2.2 Medicine

1.2.3 Surgery

1.2.4 Other

1.3 Market by Application

1.3.1 Global Androgen Deprivation Therapy (ADT) Market Growth by Application: 2020 VS 2024 VS 2031

1.3.2 Hospital

1.3.3 Clinic

1.3.4 Other

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Androgen Deprivation Therapy (ADT) Market Perspective (2020-2031)

2.2 Global Androgen Deprivation Therapy (ADT) Growth Trends by Region

2.2.1 Global Androgen Deprivation Therapy (ADT) Market Size by Region: 2020 VS 2024 VS 2031

2.2.2 Androgen Deprivation Therapy (ADT) Historic Market Size by Region (2020-2025)

2.2.3 Androgen Deprivation Therapy (ADT) Forecasted Market Size by Region (2026-2031)

2.3 Androgen Deprivation Therapy (ADT) Market Dynamics

2.3.1 Androgen Deprivation Therapy (ADT) Industry Trends

2.3.2 Androgen Deprivation Therapy (ADT) Market Drivers

2.3.3 Androgen Deprivation Therapy (ADT) Market Challenges

2.3.4 Androgen Deprivation Therapy (ADT) Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Androgen Deprivation Therapy (ADT) Players by Revenue

3.1.1 Global Top Androgen Deprivation Therapy (ADT) Players by Revenue (2020-2025)

3.1.2 Global Androgen Deprivation Therapy (ADT) Revenue Market Share by Players (2020-2025)

3.2 Global Androgen Deprivation Therapy (ADT) Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players Ranking by Androgen Deprivation Therapy (ADT) Revenue

3.4 Global Androgen Deprivation Therapy (ADT) Market Concentration Ratio

3.4.1 Global Androgen Deprivation Therapy (ADT) Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Androgen Deprivation Therapy (ADT) Revenue in 2024

3.5 Global Key Players of Androgen Deprivation Therapy (ADT) Head office and Area Served

3.6 Global Key Players of Androgen Deprivation Therapy (ADT), Product and Application

3.7 Global Key Players of Androgen Deprivation Therapy (ADT), Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

4 Androgen Deprivation Therapy (ADT) Breakdown Data by Type

4.1 Global Androgen Deprivation Therapy (ADT) Historic Market Size by Type (2020-2025)

4.2 Global Androgen Deprivation Therapy (ADT) Forecasted Market Size by Type (2026-2031)

5 Androgen Deprivation Therapy (ADT) Breakdown Data by Application

5.1 Global Androgen Deprivation Therapy (ADT) Historic Market Size by Application (2020-2025)

5.2 Global Androgen Deprivation Therapy (ADT) Forecasted Market Size by Application (2026-2031)

6 North America

6.1 North America Androgen Deprivation Therapy (ADT) Market Size (2020-2031)

6.2 North America Androgen Deprivation Therapy (ADT) Market Growth Rate by Country: 2020 VS 2024 VS 2031

6.3 North America Androgen Deprivation Therapy (ADT) Market Size by Country (2020-2025)

6.4 North America Androgen Deprivation Therapy (ADT) Market Size by Country (2026-2031)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Androgen Deprivation Therapy (ADT) Market Size (2020-2031)

7.2 Europe Androgen Deprivation Therapy (ADT) Market Growth Rate by Country: 2020 VS 2024 VS 2031

7.3 Europe Androgen Deprivation Therapy (ADT) Market Size by Country (2020-2025)

7.4 Europe Androgen Deprivation Therapy (ADT) Market Size by Country (2026-2031)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Androgen Deprivation Therapy (ADT) Market Size (2020-2031)

8.2 Asia-Pacific Androgen Deprivation Therapy (ADT) Market Growth Rate by Region: 2020 VS 2024 VS 2031

8.3 Asia-Pacific Androgen Deprivation Therapy (ADT) Market Size by Region (2020-2025)

8.4 Asia-Pacific Androgen Deprivation Therapy (ADT) Market Size by Region (2026-2031)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America Androgen Deprivation Therapy (ADT) Market Size (2020-2031)

9.2 Latin America Androgen Deprivation Therapy (ADT) Market Growth Rate by Country: 2020 VS 2024 VS 2031

9.3 Latin America Androgen Deprivation Therapy (ADT) Market Size by Country (2020-2025)

9.4 Latin America Androgen Deprivation Therapy (ADT) Market Size by Country (2026-2031)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Androgen Deprivation Therapy (ADT) Market Size (2020-2031)

10.2 Middle East & Africa Androgen Deprivation Therapy (ADT) Market Growth Rate by Country: 2020 VS 2024 VS 2031

10.3 Middle East & Africa Androgen Deprivation Therapy (ADT) Market Size by Country (2020-2025)

10.4 Middle East & Africa Androgen Deprivation Therapy (ADT) Market Size by Country (2026-2031)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Pfizer

11.1.1 Pfizer Company Details

11.1.2 Pfizer Business Overview

11.1.3 Pfizer Androgen Deprivation Therapy (ADT) Introduction

11.1.4 Pfizer Revenue in Androgen Deprivation Therapy (ADT) Business (2020-2025)

11.1.5 Pfizer Recent Development

11.2 Astellas Pharma

11.2.1 Astellas Pharma Company Details

11.2.2 Astellas Pharma Business Overview

11.2.3 Astellas Pharma Androgen Deprivation Therapy (ADT) Introduction

11.2.4 Astellas Pharma Revenue in Androgen Deprivation Therapy (ADT) Business (2020-2025)

11.2.5 Astellas Pharma Recent Development

11.3 Johnson & Johnson

11.3.1 Johnson & Johnson Company Details

11.3.2 Johnson & Johnson Business Overview

11.3.3 Johnson & Johnson Androgen Deprivation Therapy (ADT) Introduction

11.3.4 Johnson & Johnson Revenue in Androgen Deprivation Therapy (ADT) Business (2020-2025)

11.3.5 Johnson & Johnson Recent Development

11.4 Novartis International

11.4.1 Novartis International Company Details

11.4.2 Novartis International Business Overview

11.4.3 Novartis International Androgen Deprivation Therapy (ADT) Introduction

11.4.4 Novartis International Revenue in Androgen Deprivation Therapy (ADT) Business (2020-2025)

11.4.5 Novartis International Recent Development

11.5 Merck

11.5.1 Merck Company Details

11.5.2 Merck Business Overview

11.5.3 Merck Androgen Deprivation Therapy (ADT) Introduction

11.5.4 Merck Revenue in Androgen Deprivation Therapy (ADT) Business (2020-2025)

11.5.5 Merck Recent Development

11.6 Veru

11.6.1 Veru Company Details

11.6.2 Veru Business Overview

11.6.3 Veru Androgen Deprivation Therapy (ADT) Introduction

11.6.4 Veru Revenue in Androgen Deprivation Therapy (ADT) Business (2020-2025)

11.6.5 Veru Recent Development

11.7 Sanofi

11.7.1 Sanofi Company Details

11.7.2 Sanofi Business Overview

11.7.3 Sanofi Androgen Deprivation Therapy (ADT) Introduction

11.7.4 Sanofi Revenue in Androgen Deprivation Therapy (ADT) Business (2020-2025)

11.7.5 Sanofi Recent Development

11.8 GlaxoSmithKline

11.8.1 GlaxoSmithKline Company Details

11.8.2 GlaxoSmithKline Business Overview

11.8.3 GlaxoSmithKline Androgen Deprivation Therapy (ADT) Introduction

11.8.4 GlaxoSmithKline Revenue in Androgen Deprivation Therapy (ADT) Business (2020-2025)

11.8.5 GlaxoSmithKline Recent Development

11.9 Bayer

11.9.1 Bayer Company Details

11.9.2 Bayer Business Overview

11.9.3 Bayer Androgen Deprivation Therapy (ADT) Introduction

11.9.4 Bayer Revenue in Androgen Deprivation Therapy (ADT) Business (2020-2025)

11.9.5 Bayer Recent Development

11.10 Orion

11.10.1 Orion Company Details

11.10.2 Orion Business Overview

11.10.3 Orion Androgen Deprivation Therapy (ADT) Introduction

11.10.4 Orion Revenue in Androgen Deprivation Therapy (ADT) Business (2020-2025)

11.10.5 Orion Recent Development

11.11 AstraZeneca

11.11.1 AstraZeneca Company Details

11.11.2 AstraZeneca Business Overview

11.11.3 AstraZeneca Androgen Deprivation Therapy (ADT) Introduction

11.11.4 AstraZeneca Revenue in Androgen Deprivation Therapy (ADT) Business (2020-2025)

11.11.5 AstraZeneca Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

FEATURED COMPANIES

Pfizer Inc

Astellas Pharma

Johnson & Johnson

Novartis International

Merck

Veru Inc.

Sanofi

GlaxoSmithKline PLC

Bayer

Orion

Astrazeneca plc

Johnson & Johnson

List of Tables

Table 1. Global Androgen Deprivation Therapy (ADT) Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031

Table 2. Key Players of Medicine

Table 3. Key Players of Surgery

Table 4. Key Players of Other

Table 5. Global Androgen Deprivation Therapy (ADT) Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031

Table 6. Global Androgen Deprivation Therapy (ADT) Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 7. Global Androgen Deprivation Therapy (ADT) Market Size by Region (2020-2025) & (US$ Million)

Table 8. Global Androgen Deprivation Therapy (ADT) Market Share by Region (2020-2025)

Table 9. Global Androgen Deprivation Therapy (ADT) Forecasted Market Size by Region (2026-2031) & (US$ Million)

Table 10. Global Androgen Deprivation Therapy (ADT) Market Share by Region (2026-2031)

Table 11. Androgen Deprivation Therapy (ADT) Market Trends

Table 12. Androgen Deprivation Therapy (ADT) Market Drivers

Table 13. Androgen Deprivation Therapy (ADT) Market Challenges

Table 14. Androgen Deprivation Therapy (ADT) Market Restraints

Table 15. Global Androgen Deprivation Therapy (ADT) Revenue by Players (2020-2025) & (US$ Million)

Table 16. Global Androgen Deprivation Therapy (ADT) Market Share by Players (2020-2025)

Table 17. Global Top Androgen Deprivation Therapy (ADT) Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Androgen Deprivation Therapy (ADT) as of 2024)

Table 18. Ranking of Global Top Androgen Deprivation Therapy (ADT) Companies by Revenue (US$ Million) in 2024

Table 19. Global 5 Largest Players Market Share by Androgen Deprivation Therapy (ADT) Revenue (CR5 and HHI) & (2020-2025)

Table 20. Global Key Players of Androgen Deprivation Therapy (ADT), Headquarters and Area Served

Table 21. Global Key Players of Androgen Deprivation Therapy (ADT), Product and Application

Table 22. Global Key Players of Androgen Deprivation Therapy (ADT), Date of Enter into This Industry

Table 23. Mergers & Acquisitions, Expansion Plans

Table 24. Global Androgen Deprivation Therapy (ADT) Market Size by Type (2020-2025) & (US$ Million)

Table 25. Global Androgen Deprivation Therapy (ADT) Revenue Market Share by Type (2020-2025)

Table 26. Global Androgen Deprivation Therapy (ADT) Forecasted Market Size by Type (2026-2031) & (US$ Million)

Table 27. Global Androgen Deprivation Therapy (ADT) Revenue Market Share by Type (2026-2031)

Table 28. Global Androgen Deprivation Therapy (ADT) Market Size by Application (2020-2025) & (US$ Million)

Table 29. Global Androgen Deprivation Therapy (ADT) Revenue Market Share by Application (2020-2025)

Table 30. Global Androgen Deprivation Therapy (ADT) Forecasted Market Size by Application (2026-2031) & (US$ Million)

Table 31. Global Androgen Deprivation Therapy (ADT) Revenue Market Share by Application (2026-2031)

Table 32. North America Androgen Deprivation Therapy (ADT) Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 33. North America Androgen Deprivation Therapy (ADT) Market Size by Country (2020-2025) & (US$ Million)

Table 34. North America Androgen Deprivation Therapy (ADT) Market Size by Country (2026-2031) & (US$ Million)

Table 35. Europe Androgen Deprivation Therapy (ADT) Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 36. Europe Androgen Deprivation Therapy (ADT) Market Size by Country (2020-2025) & (US$ Million)

Table 37. Europe Androgen Deprivation Therapy (ADT) Market Size by Country (2026-2031) & (US$ Million)

Table 38. Asia-Pacific Androgen Deprivation Therapy (ADT) Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031

Table 39. Asia-Pacific Androgen Deprivation Therapy (ADT) Market Size by Region (2020-2025) & (US$ Million)

Table 40. Asia-Pacific Androgen Deprivation Therapy (ADT) Market Size by Region (2026-2031) & (US$ Million)

Table 41. Latin America Androgen Deprivation Therapy (ADT) Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 42. Latin America Androgen Deprivation Therapy (ADT) Market Size by Country (2020-2025) & (US$ Million)

Table 43. Latin America Androgen Deprivation Therapy (ADT) Market Size by Country (2026-2031) & (US$ Million)

Table 44. Middle East & Africa Androgen Deprivation Therapy (ADT) Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 45. Middle East & Africa Androgen Deprivation Therapy (ADT) Market Size by Country (2020-2025) & (US$ Million)

Table 46. Middle East & Africa Androgen Deprivation Therapy (ADT) Market Size by Country (2026-2031) & (US$ Million)

Table 47. Pfizer Company Details

Table 48. Pfizer Business Overview

Table 49. Pfizer Androgen Deprivation Therapy (ADT) Product

Table 50. Pfizer Revenue in Androgen Deprivation Therapy (ADT) Business (2020-2025) & (US$ Million)

Table 51. Pfizer Recent Development

Table 52. Astellas Pharma Company Details

Table 53. Astellas Pharma Business Overview

Table 54. Astellas Pharma Androgen Deprivation Therapy (ADT) Product

Table 55. Astellas Pharma Revenue in Androgen Deprivation Therapy (ADT) Business (2020-2025) & (US$ Million)

Table 56. Astellas Pharma Recent Development

Table 57. Johnson & Johnson Company Details

Table 58. Johnson & Johnson Business Overview

Table 59. Johnson & Johnson Androgen Deprivation Therapy (ADT) Product

Table 60. Johnson & Johnson Revenue in Androgen Deprivation Therapy (ADT) Business (2020-2025) & (US$ Million)

Table 61. Johnson & Johnson Recent Development

Table 62. Novartis International Company Details

Table 63. Novartis International Business Overview

Table 64. Novartis International Androgen Deprivation Therapy (ADT) Product

Table 65. Novartis International Revenue in Androgen Deprivation Therapy (ADT) Business (2020-2025) & (US$ Million)

Table 66. Novartis International Recent Development

Table 67. Merck Company Details

Table 68. Merck Business Overview

Table 69. Merck Androgen Deprivation Therapy (ADT) Product

Table 70. Merck Revenue in Androgen Deprivation Therapy (ADT) Business (2020-2025) & (US$ Million)

Table 71. Merck Recent Development

Table 72. Veru Company Details

Table 73. Veru Business Overview

Table 74. Veru Androgen Deprivation Therapy (ADT) Product

Table 75. Veru Revenue in Androgen Deprivation Therapy (ADT) Business (2020-2025) & (US$ Million)

Table 76. Veru Recent Development

Table 77. Sanofi Company Details

Table 78. Sanofi Business Overview

Table 79. Sanofi Androgen Deprivation Therapy (ADT) Product

Table 80. Sanofi Revenue in Androgen Deprivation Therapy (ADT) Business (2020-2025) & (US$ Million)

Table 81. Sanofi Recent Development

Table 82. GlaxoSmithKline Company Details

Table 83. GlaxoSmithKline Business Overview

Table 84. GlaxoSmithKline Androgen Deprivation Therapy (ADT) Product

Table 85. GlaxoSmithKline Revenue in Androgen Deprivation Therapy (ADT) Business (2020-2025) & (US$ Million)

Table 86. GlaxoSmithKline Recent Development

Table 87. Bayer Company Details

Table 88. Bayer Business Overview

Table 89. Bayer Androgen Deprivation Therapy (ADT) Product

Table 90. Bayer Revenue in Androgen Deprivation Therapy (ADT) Business (2020-2025) & (US$ Million)

Table 91. Bayer Recent Development

Table 92. Orion Company Details

Table 93. Orion Business Overview

Table 94. Orion Androgen Deprivation Therapy (ADT) Product

Table 95. Orion Revenue in Androgen Deprivation Therapy (ADT) Business (2020-2025) & (US$ Million)

Table 96. Orion Recent Development

Table 97. AstraZeneca Company Details

Table 98. AstraZeneca Business Overview

Table 99. AstraZeneca Androgen Deprivation Therapy (ADT) Product

Table 100. AstraZeneca Revenue in Androgen Deprivation Therapy (ADT) Business (2020-2025) & (US$ Million)

Table 101. AstraZeneca Recent Development

Table 102. Research Programs/Design for This Report

Table 103. Key Data Information from Secondary Sources

Table 104. Key Data Information from Primary Sources

Table 105. Authors List of This Report

List of Figures

Figure 1. Androgen Deprivation Therapy (ADT) Picture

Figure 2. Global Androgen Deprivation Therapy (ADT) Market Size Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global Androgen Deprivation Therapy (ADT) Market Share by Type: 2024 VS 2031

Figure 4. Medicine Features

Figure 5. Surgery Features

Figure 6. Other Features

Figure 7. Global Androgen Deprivation Therapy (ADT) Market Size by Application (2020-2031) & (US$ Million)

Figure 8. Global Androgen Deprivation Therapy (ADT) Market Share by Application: 2024 VS 2031

Figure 9. Hospital Case Studies

Figure 10. Clinic Case Studies

Figure 11. Other Case Studies

Figure 12. Androgen Deprivation Therapy (ADT) Report Years Considered

Figure 13. Global Androgen Deprivation Therapy (ADT) Market Size (US$ Million), Year-over-Year: 2020-2031

Figure 14. Global Androgen Deprivation Therapy (ADT) Market Size, (US$ Million), 2020 VS 2024 VS 2031

Figure 15. Global Androgen Deprivation Therapy (ADT) Market Share by Region: 2024 VS 2031

Figure 16. Global Androgen Deprivation Therapy (ADT) Market Share by Players in 2024

Figure 17. Global Top Androgen Deprivation Therapy (ADT) Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Androgen Deprivation Therapy (ADT) as of 2024)

Figure 18. The Top 10 and 5 Players Market Share by Androgen Deprivation Therapy (ADT) Revenue in 2024

Figure 19. North America Androgen Deprivation Therapy (ADT) Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 20. North America Androgen Deprivation Therapy (ADT) Market Share by Country (2020-2031)

Figure 21. United States Androgen Deprivation Therapy (ADT) Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 22. Canada Androgen Deprivation Therapy (ADT) Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 23. Europe Androgen Deprivation Therapy (ADT) Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 24. Europe Androgen Deprivation Therapy (ADT) Market Share by Country (2020-2031)

Figure 25. Germany Androgen Deprivation Therapy (ADT) Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 26. France Androgen Deprivation Therapy (ADT) Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 27. U.K. Androgen Deprivation Therapy (ADT) Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 28. Italy Androgen Deprivation Therapy (ADT) Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 29. Russia Androgen Deprivation Therapy (ADT) Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 30. Nordic Countries Androgen Deprivation Therapy (ADT) Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 31. Asia-Pacific Androgen Deprivation Therapy (ADT) Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 32. Asia-Pacific Androgen Deprivation Therapy (ADT) Market Share by Region (2020-2031)

Figure 33. China Androgen Deprivation Therapy (ADT) Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 34. Japan Androgen Deprivation Therapy (ADT) Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 35. South Korea Androgen Deprivation Therapy (ADT) Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 36. Southeast Asia Androgen Deprivation Therapy (ADT) Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 37. India Androgen Deprivation Therapy (ADT) Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 38. Australia Androgen Deprivation Therapy (ADT) Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 39. Latin America Androgen Deprivation Therapy (ADT) Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 40. Latin America Androgen Deprivation Therapy (ADT) Market Share by Country (2020-2031)

Figure 41. Mexico Androgen Deprivation Therapy (ADT) Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 42. Brazil Androgen Deprivation Therapy (ADT) Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 43. Middle East & Africa Androgen Deprivation Therapy (ADT) Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 44. Middle East & Africa Androgen Deprivation Therapy (ADT) Market Share by Country (2020-2031)

Figure 45. Turkey Androgen Deprivation Therapy (ADT) Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 46. Saudi Arabia Androgen Deprivation Therapy (ADT) Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 47. UAE Androgen Deprivation Therapy (ADT) Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 48. Pfizer Revenue Growth Rate in Androgen Deprivation Therapy (ADT) Business (2020-2025)

Figure 49. Astellas Pharma Revenue Growth Rate in Androgen Deprivation Therapy (ADT) Business (2020-2025)

Figure 50. Johnson & Johnson Revenue Growth Rate in Androgen Deprivation Therapy (ADT) Business (2020-2025)

Figure 51. Novartis International Revenue Growth Rate in Androgen Deprivation Therapy (ADT) Business (2020-2025)

Figure 52. Merck Revenue Growth Rate in Androgen Deprivation Therapy (ADT) Business (2020-2025)

Figure 53. Veru Revenue Growth Rate in Androgen Deprivation Therapy (ADT) Business (2020-2025)

Figure 54. Sanofi Revenue Growth Rate in Androgen Deprivation Therapy (ADT) Business (2020-2025)

Figure 55. GlaxoSmithKline Revenue Growth Rate in Androgen Deprivation Therapy (ADT) Business (2020-2025)

Figure 56. Bayer Revenue Growth Rate in Androgen Deprivation Therapy (ADT) Business (2020-2025)

Figure 57. Orion Revenue Growth Rate in Androgen Deprivation Therapy (ADT) Business (2020-2025)

Figure 58. AstraZeneca Revenue Growth Rate in Androgen Deprivation Therapy (ADT) Business (2020-2025)

Figure 59. Bottom-up and Top-down Approaches for This Report

Figure 60. Data Triangulation

Figure 61. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Global Antiandrogen Market Insights Forecast to 2030

Global Androgen Antagonist Market Insights Forecast to 2030

Global Male Infertility Treatment Market Insights Forecast to 2030

Global Male Hypogonadism Therapy Market Insights Forecast to 2030

Global Cancer Hormone Therapy Drugs Market Insights Forecast to 2030

Prostate Cancer Hormone Therapy Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Testosterone Replacement Therapy Market Insights Forecast to 2030

Global Adjuvant Therapy Market Research Report 2024

Global Drugs For Hormonal Replacement Market Insights Forecast to 2030

Androgenetic Alopecia Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Hypogonadism Treatment Market Research Report 2025

Global Penile Cancer Treatment Market Insights Forecast to 2030

Global Antihormonal Cancer Therapies Market Insights Forecast to 2030

Global Androgenic Alopecia Therapeutics Market Insights Forecast to 2030

Global Hormone Releasing Agonists Market Research Report 2024

Global Hypogonadism Drug Market Research Report 2025

Global Breast Cancer Hormone Therapy Market Insights Forecast to 2030

Global Solid Tumor Cancer Treatment Market Insights Forecast to 2030

Global Erectile Dysfunction Treatment Market Insights Forecast to 2030

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions